title: A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom?
authors.forename: Chi-Un
authors.initials: CU
authors.lastname: Pae
authors.forename: David M
authors.initials: DM
authors.lastname: Marks
authors.forename: Changsu
authors.initials: C
authors.lastname: Han
authors.forename: Ashwin A
authors.initials: AA
authors.lastname: Patkar
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology*; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006212:Hallucinations / Q000139:chemically induced* / Q000523:psychology; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011605:Psychoses, Substance-Induced / Q000523:psychology*; D012919:Social Behavior
chemical_list: D000928:Antidepressive Agents; D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole